MAHE and Novo Nordisk GBS expand collaboration in pharmacometrics

Wednesday, July 8, 2026 - 20:44
0 0
MAHE and Novo Nordisk GBS expand collaboration in pharmacometrics
Novo Nordisk GBS will provide financial support of ₹1.75 crore over five years to enhance specialised talent development, research capacity and advanced infrastructure in quantitative drug development.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User